vs
Side-by-side financial comparison of Citius Pharmaceuticals, Inc. (CTXR) and QUICKLOGIC Corp (QUIK). Click either name above to swap in a different company.
QUICKLOGIC Corp is the larger business by last-quarter revenue ($5.7M vs $3.9M, roughly 1.4× Citius Pharmaceuticals, Inc.). QUICKLOGIC Corp runs the higher net margin — -5.4% vs -238.2%, a 232.8% gap on every dollar of revenue.
Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing innovative prescription therapies addressing unmet medical needs across critical care, oncology, anti-infective treatment, and supportive care segments, primarily serving the U.S. healthcare market.
QuickLogic Corp is a fabless semiconductor company developing low-power customizable FPGAs, embedded FPGA IP, and edge sensor processing solutions. Its offerings serve global wearables, IoT, mobile electronics, and industrial markets, enabling energy-efficient low-latency on-device processing for edge AI and sensing use cases.
CTXR vs QUIK — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2024
| Metric | | |
|---|---|---|
| Revenue | $3.9M | $5.7M |
| Net Profit | $-9.4M | $-305.0K |
| Gross Margin | 80.0% | 62.7% |
| Operating Margin | -228.7% | 2.6% |
| Net Margin | -238.2% | -5.4% |
| Revenue YoY | — | -24.1% |
| Net Profit YoY | 8.6% | -114.9% |
| EPS (diluted) | $-0.38 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.9M | — | ||
| Q4 24 | — | $5.7M | ||
| Q3 24 | — | $4.2M | ||
| Q2 24 | — | $4.1M | ||
| Q1 24 | — | $5.7M | ||
| Q4 23 | — | $6.7M | ||
| Q3 23 | — | $2.9M | ||
| Q2 23 | — | $4.1M |
| Q4 25 | $-9.4M | — | ||
| Q4 24 | — | $-305.0K | ||
| Q3 24 | — | $-2.1M | ||
| Q2 24 | — | $-1.6M | ||
| Q1 24 | — | $108.0K | ||
| Q4 23 | — | $1.2M | ||
| Q3 23 | — | $-2.3M | ||
| Q2 23 | — | $-1.2M |
| Q4 25 | 80.0% | — | ||
| Q4 24 | — | 62.7% | ||
| Q3 24 | — | 59.1% | ||
| Q2 24 | — | 54.7% | ||
| Q1 24 | — | 67.1% | ||
| Q4 23 | — | 76.9% | ||
| Q3 23 | — | 41.2% | ||
| Q2 23 | — | 57.8% |
| Q4 25 | -228.7% | — | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | -38.1% | ||
| Q2 24 | — | -29.3% | ||
| Q1 24 | — | 2.3% | ||
| Q4 23 | — | 19.2% | ||
| Q3 23 | — | -76.2% | ||
| Q2 23 | — | -26.6% |
| Q4 25 | -238.2% | — | ||
| Q4 24 | — | -5.4% | ||
| Q3 24 | — | -49.8% | ||
| Q2 24 | — | -37.8% | ||
| Q1 24 | — | 1.9% | ||
| Q4 23 | — | 17.9% | ||
| Q3 23 | — | -77.7% | ||
| Q2 23 | — | -29.7% |
| Q4 25 | $-0.38 | — | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | — | $-0.14 | ||
| Q2 24 | — | $-0.11 | ||
| Q1 24 | — | $0.01 | ||
| Q4 23 | — | $0.08 | ||
| Q3 23 | — | $-0.17 | ||
| Q2 23 | — | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.7M | — |
| Total DebtLower is stronger | — | $3.1M |
| Stockholders' EquityBook value | $80.0M | $24.9M |
| Total Assets | $140.4M | $51.9M |
| Debt / EquityLower = less leverage | — | 0.12× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | — | — | ||
| Q4 24 | — | $3.1M | ||
| Q3 24 | — | $3.4M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $1.4M | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | $80.0M | — | ||
| Q4 24 | — | $24.9M | ||
| Q3 24 | — | $20.9M | ||
| Q2 24 | — | $21.8M | ||
| Q1 24 | — | $22.2M | ||
| Q4 23 | — | $14.0M | ||
| Q3 23 | — | $12.2M | ||
| Q2 23 | — | $13.7M |
| Q4 25 | $140.4M | — | ||
| Q4 24 | — | $51.9M | ||
| Q3 24 | — | $49.7M | ||
| Q2 24 | — | $47.5M | ||
| Q1 24 | — | $51.9M | ||
| Q4 23 | — | $36.5M | ||
| Q3 23 | — | $34.4M | ||
| Q2 23 | — | $34.7M |
| Q4 25 | — | — | ||
| Q4 24 | — | 0.12× | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | 0.06× | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-13.0M | $116.0K |
| Free Cash FlowOCF − Capex | — | $-1.2M |
| FCF MarginFCF / Revenue | — | -20.6% |
| Capex IntensityCapex / Revenue | — | 22.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-5.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-13.0M | — | ||
| Q4 24 | — | $116.0K | ||
| Q3 24 | — | $-16.0K | ||
| Q2 24 | — | $-220.0K | ||
| Q1 24 | — | $147.0K | ||
| Q4 23 | — | $130.0K | ||
| Q3 23 | — | $38.0K | ||
| Q2 23 | — | $-359.0K |
| Q4 25 | — | — | ||
| Q4 24 | — | $-1.2M | ||
| Q3 24 | — | $-83.0K | ||
| Q2 24 | — | $-4.2M | ||
| Q1 24 | — | $62.0K | ||
| Q4 23 | — | $-1.5M | ||
| Q3 23 | — | $-47.0K | ||
| Q2 23 | — | $-361.0K |
| Q4 25 | — | — | ||
| Q4 24 | — | -20.6% | ||
| Q3 24 | — | -2.0% | ||
| Q2 24 | — | -102.2% | ||
| Q1 24 | — | 1.1% | ||
| Q4 23 | — | -22.7% | ||
| Q3 23 | — | -1.6% | ||
| Q2 23 | — | -8.7% |
| Q4 25 | — | — | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 1.6% | ||
| Q2 24 | — | 96.9% | ||
| Q1 24 | — | 1.5% | ||
| Q4 23 | — | 24.7% | ||
| Q3 23 | — | 2.9% | ||
| Q2 23 | — | 0.0% |
| Q4 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.36× | ||
| Q4 23 | — | 0.11× | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTXR
Segment breakdown not available.
QUIK
| North America | $3.0M | 53% |
| Other | $2.7M | 47% |
